Michael Salsbury - 09 Jun 2022 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (MTVA)

Role
Director
Signature
/s/ Michael Salsbury
Issuer symbol
MTVA
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 17:22:25 UTC
Next filing
28 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRBO Nonstatutory Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 09 Jun 2022 Common Stock 20,000 $0.4725 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests on the earlier of June 9, 2023 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.